A carregar...

Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis

Lenalidomide is associated with increased risk of thromboembolism (VTE) in patients with multiple myeloma. This risk has not previously been defined in B-cell non-Hodgkin lymphoma (NHL), for which lenalidomide is also an active agent. We conducted a systematic literature search in Ovid MEDLINE (1946...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Yamshon, Samuel, Christos, Paul J., Demetres, Michelle, Hammad, Hoda, Leonard, John P., Ruan, Jia
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020807/
https://ncbi.nlm.nih.gov/pubmed/29934343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016683
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!